Cancer Immunotherapy
Nivolumab
BPT-1202 · Intravenous injection
What is it used for?
An antibody that blocks PD-1 to support immune responses against cancer. Used for selected lung, kidney, melanoma, colorectal and other cancers, alone or in specific combinations. Some indications require particular tumor biomarkers.
- Dosage form
- Intravenous injection
- Listed strengths
- 100 mg/10 mL & 40 mg/4 mL
- Listed pack size
- 1's
- Mechanism
- PD-1 immune checkpoint inhibitor
Specifications supplied in the Everest product list; formulation, pack configuration, availability and local authorization require confirmation. These medicines are not for self-medication.
Clinical use overview
- Selected lung and kidney cancers
- Melanoma
- Selected colorectal cancers
Important information
Educational information about the active ingredient, not a treatment recommendation or a claim that Beptide's presentation is approved. Approved uses differ by country and product. Cancer medicines require specialist assessment; biomarkers, stage, previous treatments and combinations can determine eligibility.
FDA prescribing information